Zobrazeno 1 - 10
of 138
pro vyhledávání: '"fibroproliferation"'
Autor:
Zhihui Zhang, Rujian Li, Yubiao Chen, Jierong Zhang, Yongxin Zheng, Minmin Xu, Jiaqi Liang, Jiahui Li, Yongbo Huang, Yonghao Xu, Weiqun He, Xiaoqing Liu, Yimin Li
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Cytomegalovirus (CMV) has high seroprevalence, and its active infection is associated with several adverse prognoses in adult patients with acute respiratory distress syndrome (ARDS). However, the role of active CMV infection in A
Externí odkaz:
https://doaj.org/article/03ac9bf6e4f244208c3a993f8f397a6d
Autor:
Rajesh K Kasam, Sudhir Ghandikota, Divyalakshmi Soundararajan, Geereddy B Reddy, Steven K Huang, Anil G Jegga, Satish K Madala
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 9, Pp 1-16 (2020)
Abstract Fibroblast activation including proliferation, survival, and ECM production is central to initiation and maintenance of fibrotic lesions in idiopathic pulmonary fibrosis (IPF). However, druggable molecules that target fibroblast activation r
Externí odkaz:
https://doaj.org/article/2a97e233e5134721ba0d532a1b18172e
Autor:
Annabelle Hamon, Ugo Scemama, Jérémy Bourenne, Florence Daviet, Benjamin Coiffard, Nicolas Persico, Mélanie Adda, Christophe Guervilly, Sami Hraiech, Kathia Chaumoitre, Antoine Roch, Laurent Papazian, Jean-Marie Forel
Publikováno v:
Annals of Intensive Care, Vol 9, Iss 1, Pp 1-8 (2019)
Abstract Background Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproli
Externí odkaz:
https://doaj.org/article/44a6b2eb0e8346fda06ac47e6fb041b0
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly understood. While most sources agree that IPF does not result from a primary immunopathogenic mechanism, evidence gleaned from animal modeling and human studi
Externí odkaz:
https://doaj.org/article/dcccd9bd42c64718ad65018ec95870b5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lili eGao, Haiying eTang, Huanyu eHe, Jia eLiu, Jingwei eMao, Hong eJi, Hongli eLin, Taihua eWu
Publikováno v:
Frontiers in Pharmacology, Vol 6 (2015)
Idiopathic pulmonary fibrosis is a progressive and lethal form of interstitial lung disease that lacks effective therapies at present. Glycyrrhizic acid (GA), a natural compound extracted from a traditional Chinese herbal medicine Glycyrrhiza glabra,
Externí odkaz:
https://doaj.org/article/11fb0b866d3440aabf4279801c721227
Autor:
Christophe Guervilly, Antoine Roch, Benjamin Coiffard, Mélanie Adda, Florence Daviet, Nicolas Persico, Kathia Chaumoitre, Jean-Marie Forel, Sami Hraiech, Annabelle Hamon, Jeremy Bourenne, Ugo Scemama, Laurent Papazian
Publikováno v:
Annals of Intensive Care, Vol 9, Iss 1, Pp 1-8 (2019)
Annals of Intensive Care
Annals of Intensive Care, 2019, 9 (1), pp.42. ⟨10.1186/s13613-019-0516-9⟩
Annals of Intensive Care
Annals of Intensive Care, 2019, 9 (1), pp.42. ⟨10.1186/s13613-019-0516-9⟩
Background Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d5b6264e85268522bd1a09b8f94f6f
http://link.springer.com/article/10.1186/s13613-019-0516-9
http://link.springer.com/article/10.1186/s13613-019-0516-9
Autor:
Dong Soon Kim
Publikováno v:
Interstitial Lung Disease
Respiratory Research
Respiratory Research
Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial lung disease that primarily affects older adults. Median survival after diagnosis is 2–3 years. The clinical course of IPF may include periods of acute deterioration in respir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf32ba701974017233d69f78b4b57c7f
http://europepmc.org/articles/PMC7151865
http://europepmc.org/articles/PMC7151865
Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease leading to respiratory failure, and ultimately to death. It is characterized by marked heterogeneity regarding its clinical course. Despite significant progress in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e31bd6ec8ab69aa7af0b98a7fa5511
http://hdl.handle.net/10807/147495
http://hdl.handle.net/10807/147495
